Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial.
Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial.
复制标题
完全胃系膜切除术治疗局部晚期胃癌:随机临床试验的短期结果
DOI:
10.1016/j.xcrm.2021.100217
复制
发表时间:
2021-03-16
期刊:
影响因子:
--
通讯作者:
Gong J
中科院分区:
文献类型:
--
作者:
Xie D;Shen J;Liu L;Cao B;Wang Y;Qin J;Wu J;Yan Q;Hu Y;Yang C;Cao Z;Hu J;Yin P;Gong J
Implementation of complete mesogastric excision in gastric cancer surgery, named D2 lymphadenectomy plus complete mesogastric excision (D2+CME), has recently been proposed as an optimal procedure. However, the safety and efficacy of D2+CME remain uncertain. In this randomized controlled trial, patients receiving D2+CME exhibit less intraoperative blood loss, more lymph node harvesting, and earlier postoperative flatus than patients receiving conventional D2 radical surgery. Univariate Cox regression analysis reveals that the risk ratio for postoperative flatus in D2+CME group is 1.247 (p = 0.044). Overall postoperative complications are comparable between the two groups, but complications are significantly less severe in the D2+CME group than the D2 group (Clavien-Dindo classification grade ≥ IIIa: 4 D2+CME patients [11.8%] versus 9 D2 patients [33.3%]; p = 0.041). In conclusion, our work shows that D2+CME is associated with better short-term outcomes and surgical safety than conventional D2 dissection for patients with advanced gastric cancer. Gastric cancer patients receiving D2+CME exhibit less intraoperative blood loss The number of lymph nodes harvested with D2+CME is significantly improved D2+CME surgery could provide faster postoperative flatus D2+CME is less likely to cause severe complications than conventional surgery Xie et al. demonstrate the short-term outcomes of a surgical procedure named D2+CME in gastric cancer patients. They compare D2+CME with conventional D2 radical surgery and show that D2+CME has better outcomes and surgical safety. This provides an optimal surgical approach for patients with gastric cancer.
登录
查看更多内容
影响因子:
2.5
作者:
Shen J;Cao B;Wang Y;Xiao A;Qin J;Wu J;Yan Q;Hu Y;Yang C;Cao Z;Hu J;Yin P;Xie D;Gong J
通讯作者:
Gong J
影响因子:
120.7
作者:
Yu, Jiang;Huang, Changming;Wang, Baolin
通讯作者:
Wang, Baolin
影响因子:
4.7
作者:
Xie, Daxing;Osaiweran, Hasan;Gong, Jianping
通讯作者:
Gong, Jianping
影响因子:
3.4
作者:
Hohenberger, W.;Weber, K.;Merkel, S.
通讯作者:
Merkel, S.
DOI:
10.1007/s00464-016-4847-4
发表时间:
2016-11-01
影响因子:
3.1
作者:
Xie, Daxing;Yu, Chaoran;Gong, Jianping
通讯作者:
Gong, Jianping